Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety Profile

procarbazine is covered as methylhydrazine antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Methylhydrazine antineoplastic agents; hazardous antineoplastic medicine. Procarbazine.

Procarbazine.

Its mechanism is incompletely defined but includes inhibition of DNA, RNA and protein synthesis, likely through alkylating metabolites; it can cross the blood-brain barrier.

Procarbazine is a named component of MOPP and LOPP lymphoma protocols and has been discussed for selected brain-tumour or inflammatory contexts. A component page does not itself define a complete protocol.

Procarbazine is a named component of MOPP and LOPP lymphoma protocols and has been discussed for selected brain-tumour or inflammatory contexts. A component page does not itself define a complete protocol.

Oral hazardous chemotherapy as part of a specialist protocol

Veterinary evidence is strongest as part of combination lymphoma regimens rather than as an isolated universal agent. MOPP and LOPP have different alkylators and cannot be treated as the same schedule.

Nausea, vomiting, diarrhoea and marrow suppression are recognised. It is hazardous oral chemotherapy, and human product interaction warnings require veterinary pharmacy review before use in an animal.

Other marrow suppressants, serotonergic or sympathomimetic medicines and dietary or drug interactions described for procarbazine require case-specific assessment. Owners should not build an interaction list from human internet advice alone.

No FDA-approved canine or feline oncology indication was established for this medicine in this audit. In the United States, veterinary oncology use of an approved human or animal formulation is extra-label and must occur under a veterinarian within AMDUCA conditions and a valid VCPR.

Multi-region specialist use; product availability, extra-label prescribing law and pharmacy handling vary by jurisdiction.

The oncology team reviews all medicines and supplements, establishes baseline blood counts and organ function and sets protocol-specific follow-up. Fever, bleeding, severe gastrointestinal signs or neurologic change require prompt contact. No dose or food rule is supplied here.